- Filed
- Oct 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 23, 2025 | 415.91M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 429.47M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 424.67M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 413.88M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 397.96M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $75M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $0 |
| Capex | Q3 2025 · Sep 30, 2025 | $70M |
| Capex | Q3 2025 · Sep 30, 2024 | $66M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $377M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $337M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $2.75B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $2.75B |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $5M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $4M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $555M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $499M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $3.28B |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $3.17B |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $2.98B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $2.95B |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $2.97B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $2.84B |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $2.3B |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $2.07B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $2.03B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.89B |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $5.45B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $5.2B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $3.01B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $2.66B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $8.72B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $8.15B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.20 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.43 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | $0.15 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.49 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.20 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.44 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | $0.15 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.49 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $489M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $1.42B |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $425M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $1.24B |
| Net Income | Q3 2025 · Sep 30, 2025 | $93M |
| Net Income | Q3 2025 · Sep 30, 2025 | $205M |
| Net Income | Q3 2025 · Jun 30, 2025 | $77M |
| Net Income | Q3 2025 · Mar 31, 2025 | $35M |
| Net Income | Q3 2025 · Sep 30, 2024 | $69M |
| Net Income | Q3 2025 · Sep 30, 2024 | $183M |
| Net Income | Q3 2025 · Jun 30, 2024 | $69M |
| Net Income | Q3 2025 · Mar 31, 2024 | $45M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $163M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $390M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $142M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $368M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $652M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $1.81B |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $567M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $1.6B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $1.43B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $3.99B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $1.26B |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $3.55B |
| Revenue | Q3 2025 · Sep 30, 2025 | $2.09B |
| Revenue | Q3 2025 · Sep 30, 2025 | $5.79B |
| Revenue | Q3 2025 · Sep 30, 2024 | $1.83B |
| Revenue | Q3 2025 · Sep 30, 2024 | $5.16B |